tirzepatide indications fda Back to routine postings! Here's a high level overview of tirzepatide. 💊 is a dual GIP/GLP-1 receptor agonists. GIP & GLP-1 are both incretins, so some refer to this drug as Brenipatide vs Tirzepatide: 2026 Comparison

In a microplate reader the mOD/min obtained were reduced by 50% for both kits (light path approximately 4 mm)

I shared via Instagram Reels how I came about being on Ozempic, as well as the benefits I was experiencing

Supporting research nutrition Tirzepatide research that involves metabolic endpoints often pairs the compound with specific nutritional protocols

1.8 mg n = 30) without diabetes following 5 weeks treatment (titrated from 0.6 mg subcutaneously and increased in increments of 0.6 mg per week, up to end doses of 1.8 and 3.0 mg)

SPPS allows precise assembly of each amino acid in the retatrutide sequence, including the incorporation of modifications designed to improve molecular stability

What Happens When People Stop GLP-1 Therapy Stopping GLP-1 therapy usually leads to weight regain and reversal of metabolic improvements